Mimedx (MDXG) Shareholder's Equity (QoQ) (2011 - 2026)
Mimedx (MDXG) Shareholder's Equity (QoQ) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Mimedx |
534.41 Mn |
374.63 Mn |
41.62 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-5.31% |
| Dec 31, 2025 |
7.37% |
| Sep 30, 2025 |
10.30% |
| Jun 30, 2025 |
6.83% |
| Mar 31, 2025 |
5.01% |
| Dec 31, 2024 |
6.68% |
| Sep 30, 2024 |
7.72% |
| Jun 30, 2024 |
7.90% |
| Mar 31, 2024 |
9.12% |
| Dec 31, 2023 |
10,630.60% |
| Sep 30, 2023 |
110.50% |
| Jun 30, 2023 |
29.42% |
| Mar 31, 2023 |
0.23% |
| Dec 31, 2022 |
7.85% |
| Sep 30, 2022 |
-43.50% |
| Jun 30, 2022 |
-82.98% |
| Mar 31, 2022 |
-9,165.85% |
| Dec 31, 2021 |
101.41% |
| Sep 30, 2021 |
18.62% |
| Jun 30, 2021 |
11.35% |
